59878-57-8

Basic information

• Product Name: 1-(CYCLOPROPANECARBONYL)PIPERAZINE 97
• Synonyms: 1-(CYCLOPROPANECARBONYL)PIPERAZINE 97;1-(Cyclopropylcarbonyl)piperazine, 97%;Piperazine, 1-(cyclopropylcarbonyl)- (9CI);1-(Cyclopropylcarbonyl)piperazine hydrochloride 97%;Cyclopropyl(piperazin-1-yl)methan-1-one hydrochloride;Piperazine, 1-(cyclopropylcarbonyl)-;N-(Cyclopropylcarbonyl)piperazine;1-(Cyclopropylcarbonyl)piperazine, 97% colorless to pale brown liquid
• CAS NO: 59878-57-8
• Molecular Formula: C₈H₁₄N₂O
• Molecular Weight: 154.20956
• Product Categories: PIPERIDINE;Acids and Derivatives;Amines and Anilines;API intermediates;Building Blocks;Heterocyclic Building Blocks;Piperazines
• Mol File: 59878-57-8.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 120 °C0.15 mm Hg
• Flash Point: >230 °F
• Appearance: Colorless to pale brown/Liquid
• Density: 1.087 g/mL at 25 °C
• Vapor Pressure: 0.00082mmHg at 25°C
• Refractive Index: n20/D 1.524
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 8.47±0.10(Predicted)
• CAS DataBase Reference: 1-(CYCLOPROPANECARBONYL)PIPERAZINE 97(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(CYCLOPROPANECARBONYL)PIPERAZINE 97(59878-57-8)
• EPA Substance Registry System: 1-(CYCLOPROPANECARBONYL)PIPERAZINE 97(59878-57-8)

Safety Data

• Hazard Codes: Xi
• Statements: 37/38-41
• Safety Statements: 26-36/37/39
• WGK Germany: 2
• Hazardous Substances Data: 59878-57-8(Hazardous Substances Data)

Usage

Uses

1-(Cyclopropylcarbonyl)piperazine

InChI:InChI=1/C8H14N2O/c11-8(7-1-2-7)10-5-3-9-4-6-10/h7,9H,1-6H2

Upstream product

• 362474-71-3 (4-benzylpiperazin-1-yl)(cyclopropyl)methanone 
• 414910-15-9 4-(cyclopropanecarbonyl)piperazine-1-carboxylic acid tert-butyl ester 
• 629625-92-9 Benzyl 4-(cyclopropylcarbonyl)piperazin-1-carboxylate 

Downstream Products

• 57184-25-5 1-cyclopropylmethylpiperazine 
• 1242180-35-3 (S)-tert-butyl 1-{8-chloro-2-[4-(cyclopropanecarbonyl)piperazin-1-yl]quinolin-3-yl}ethylcarbamate 
• 1242180-33-1 (S)-N-(1-{2-[4-(cyclopropanecarbonyl)piperazin-1-yl]-8-methylquinolin-3-yl}ethyl)-2,2,2-trifluoroacetamide 
• 1306784-76-8 C₂₀H₂₅FN₄O 
• 1306784-75-7 (cyclopropyl)(4-{7-fluoro-8-methyl-3-[(1S)-1-(pyrido[3,2-d]pyrimidin-4-ylamino)ethyl]quinolin-2-yl}piperazin-1-yl)methynone 
• 1256280-39-3 C₂₅H₃₃FN₄O₃ 
• 1422374-59-1 C₂₃⁽¹⁴⁾CH₂₃FN₄O₃ 
• 763113-22-0 olaparib 

Relevant articles and documents

Benzofuran derivative as well as preparation method and medical application thereof

The invention relates to benzofuran derivatives, and a preparation method and medical application thereof. Specifically, the present invention relates to a new benzofuran derivative represented by general formula (I), a preparation method thereof, a pharmaceutical composition containing the derivative, and application of the composition as a therapeutic agent, especially as a PAR-4 antagonist, wherein each substituent of general formula (I) is as defined in the specification.

POLY (ADP-RIBOSE) POLYMERASE INHIBITOR

Disclosed are a phthalic hydrazide (phthalazine ketone) compound, and a pharmaceutical composition comprising the same. As a DNA repair enzyme poly (ADP-ribozyme) polymerase inhibitor, the compound and the pharmaceutical composition can effectively treat diseases involving PARP enzymatic activity, including cancer, neural degenerative diseases, inflammation and the like.

PYRROLO[2,1-F] [1,2,4] TRIAZIN-4-YLAMINES IGF-1R KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER HYPERPROLIFERATIVE DISEASES

-